DES 6
Alternative Names: DES-6Latest Information Update: 02 Oct 2021
At a glance
- Originator AusAm Biotechnologies
- Class Antivirals
- Mechanism of Action Virus attachment inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cytomegalovirus infections; Herpes simplex virus infections; HIV infections; Smallpox
Most Recent Events
- 05 Jan 2007 Discontinued - Preclinical for Cytomegalovirus infections treatment in USA (unspecified route)
- 05 Jan 2007 Discontinued - Preclinical for Herpes simplex virus infections prevention in USA (Topical)
- 05 Jan 2007 Discontinued - Preclinical for HIV infections prevention in USA (Topical)